357 related articles for article (PubMed ID: 27149811)
21. Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.
Scholze A; Liu Y; Pedersen L; Xia S; Roth HJ; Hocher B; Rasmussen LM; Tepel M
J Clin Endocrinol Metab; 2014 May; 99(5):E855-61. PubMed ID: 24606097
[TBL] [Abstract][Full Text] [Related]
22. The Association of Fibroblast Growth Factor 23 with Arterial Stiffness and Atherosclerosis in Patients with Autosomal Dominant Polycystic Kidney Disease.
Coban M; Inci A; Yılmaz U; Asilturk E
Kidney Blood Press Res; 2018; 43(4):1160-1173. PubMed ID: 30064143
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor 23 and Klotho as cardiovascular risk factors in heart transplant recipients.
Przybylowski P; Wasilewski G; Janik L; Kozlowska S; Nowak E; Malyszko J
Transplant Proc; 2014 Oct; 46(8):2848-51. PubMed ID: 25380933
[TBL] [Abstract][Full Text] [Related]
24. Alpha Klotho and Fibroblast Growth Factor-23 Among Alcoholics.
Quintero-Platt G; González-Reimers E; Rodríguez-Gaspar M; Martín-González C; Pérez-Hernández O; Romero-Acevedo L; Espelosín-Ortega E; Vega-Prieto MJ; Santolaria-Fernández F
Alcohol Alcohol; 2017 Sep; 52(5):542-549. PubMed ID: 28651327
[TBL] [Abstract][Full Text] [Related]
25. High serum soluble α-Klotho levels in patients with autosomal dominant polycystic kidney disease.
Sari F; Inci A; Dolu S; Ellidag HY; Cetinkaya R; Ersoy FF
J Investig Med; 2017 Feb; 65(2):358-362. PubMed ID: 27733443
[TBL] [Abstract][Full Text] [Related]
26. The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study.
Kim HJ; Kang E; Oh YK; Kim YH; Han SH; Yoo TH; Chae DW; Lee J; Ahn C; Oh KH
BMC Nephrol; 2018 Mar; 19(1):51. PubMed ID: 29506503
[TBL] [Abstract][Full Text] [Related]
27. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N
PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
[TBL] [Abstract][Full Text] [Related]
28. [Effects of keto/amino acids and a low-protein diet on the nutritional status of patients with Stages 3B-4 chronic kidney disease].
Milovanova SY; Milovanov YS; Taranova MV; Dobrosmyslov IA
Ter Arkh; 2017; 89(6):30-33. PubMed ID: 28745686
[TBL] [Abstract][Full Text] [Related]
29. [Low serum Klotho level as a predictor of calcification of the heart and blood vessels in patients with CKD stages 2-5D].
Milovanova LY; Lysenko Kozlovskaya LV; Milovanova SY; Taranova MV; Kozlov VV; Reshetnikov VA; Lebedeva MV; Androsova TV; Zubacheva DO; Chebotareva NV
Ter Arkh; 2020 Jul; 92(6):37-45. PubMed ID: 33346491
[TBL] [Abstract][Full Text] [Related]
30. [Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor 23 and Klotho].
Milovanova LIu; Kozlovskaia LV; Milovanov IuS; Bobkova IN; Dobrosmyslov IA
Ter Arkh; 2010; 82(6):66-72. PubMed ID: 20731116
[TBL] [Abstract][Full Text] [Related]
31. [Potential application of fibroblast growth factor 23-klotho axis in chronic kidney disease].
Lacroix JS; Urena-Torres P
Nephrol Ther; 2020 Mar; 16(2):83-92. PubMed ID: 31843356
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of fibroblast growth factor-23 and soluble alpha klotho in different stages of chronic kidney disease.
Khodeir SA; Okda HI; Abdalal HM
Saudi J Kidney Dis Transpl; 2019; 30(1):108-118. PubMed ID: 30804272
[TBL] [Abstract][Full Text] [Related]
33. [The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease].
Mukhin NA; Milovanov YS; Kozlovskaya LV; Dobrosmyslov IA; Milovanova LY
Ter Arkh; 2016; 88(4):41-45. PubMed ID: 27070162
[TBL] [Abstract][Full Text] [Related]
34. The effect of nephrectomy on Klotho, FGF-23 and bone metabolism.
Kakareko K; Rydzewska-Rosolowska A; Brzosko S; Gozdzikiewicz-Lapinska J; Koc-Zorawska E; Samocik P; Kozlowski R; Mysliwiec M; Naumnik B; Hryszko T
Int Urol Nephrol; 2017 Apr; 49(4):681-688. PubMed ID: 28130714
[TBL] [Abstract][Full Text] [Related]
35. FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study.
Desbiens LC; Sidibé A; Ung RV; Fortier C; Munger M; Wang YP; Bisson SK; Marquis K; Agharazii M; Mac-Way F
Osteoporos Int; 2018 Oct; 29(10):2345-2353. PubMed ID: 29959497
[TBL] [Abstract][Full Text] [Related]
36. Plasma levels of fibroblast growth factor-23 are associated with muscle mass in haemodialysis patients.
Fukasawa H; Ishigaki S; Kinoshita-Katahashi N; Niwa H; Yasuda H; Kumagai H; Furuya R
Nephrology (Carlton); 2014 Dec; 19(12):784-90. PubMed ID: 25185859
[TBL] [Abstract][Full Text] [Related]
37. Soluble Klotho and fibroblast growth factor 23 levels in diabetic nephropathy with different stages of albuminuria.
Inci A; Sari F; Coban M; Olmaz R; Dolu S; Sarıkaya M; Yılmaz N
J Investig Med; 2016 Aug; 64(6):1128-33. PubMed ID: 27323770
[TBL] [Abstract][Full Text] [Related]
38. [Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
Milovanov YS; Mukhin NA; Kozlovskaya LV; Milovanova SY; Markina MM
Ter Arkh; 2016; 88(6):21-25. PubMed ID: 27296257
[TBL] [Abstract][Full Text] [Related]
39. Klotho levels: association with insulin resistance and albumin-to-creatinine ratio in type 2 diabetic patients.
Silva AP; Mendes F; Pereira L; Fragoso A; Gonçalves RB; Santos N; Rato F; Neves PL
Int Urol Nephrol; 2017 Oct; 49(10):1809-1814. PubMed ID: 28677090
[TBL] [Abstract][Full Text] [Related]
40. Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy.
Farías-Basulto A; Martínez-Ramírez HR; Gómez-García EF; Cueto-Manzano AM; Cortés-Sanabria L; Hernández-Ramos LE; Ramírez-López G; Mendoza-Carrera F
Arch Med Res; 2018 Oct; 49(7):451-455. PubMed ID: 30718148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]